NCT02126865View on ClinicalTrials.gov

Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Asthma
Interventions
DRUG

Placebo to BI 1060469

tablet

DRUG

BI 1060469 Healthy

tablet

DRUG

Placebo to BI 1060469 asthmatics

tablet

DRUG

BI 1060469 asthmatics

tablet

Trial Locations (1)

Unknown

1333.2.1 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY